News in the Life Sciences Industry

STOCKHOLM, June 26, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by the European Patent Office. The patent provides additional protection for the use of certain dosage regimens... Read more ››

STOCKHOLM, June 26, 2019 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that patient enrolment was completed in the dose optimisation study CONDUCT, which is evaluating cobitolimod for the treatment of moderate to severe ulcerative colitis. Top line results are expected... Read more ››

REYKJAVIK, Iceland, June 25, 2019 /PRNewswire/ -- Twenty-two accomplished para-athletes, including many of the world's most renowned and decorated Paralympians from across the globe, have been named to Team Össur, the global prosthetics and orthopaedics innovator announced today.

STOCKHOLM, June 25, 2019 /PRNewswire/ -- Sobi(TM) presents data at the ISTH 2019: The 27th Congress of the International Society on Thrombosis and Haemostasis, Melbourne, Australia, 6 - 10 July 2019, focusing on the use of Elocta® and Alprolix® in clinical settings such as treatment switches... Read more ››

NEW YORK and STOCKHOLM, June 25, 2019 /PRNewswire/ -- Avista Capital Partners ("Avista"), a leading private equity firm focused on growth-oriented healthcare businesses, today announced that Karo Pharma AB (publ) (the "Company" or "Karo Pharma"), a specialty pharma company, has acquired all the... Read more ››

GOTHENBURG, Sweden, June 25, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced approval of a Clinical Use Patent for arfolitixorin in the United States. The patent expires in 2038 and is the second patent in a series of clinical patent applications... Read more ››

MALMÖ, Sweden, June 25, 2019 /PRNewswire/ -- Thor A. Alvegard, MD, PhD, is a distinguished biographee of Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are chosen from among a pool of the most prominent professionals and are selected on the basis of... Read more ››

STOCKHOLM, June 25, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it received regulatory approval for its flagship product, IRRAflow,... Read more ››

SINGAPORE, June 24, 2019 /PRNewswire/ -- Gilead Sciences, Inc. today announced that the Singapore Health Sciences Authority has approved Vosevi (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg), a once-daily single tablet regimen for the re-treatment of adults with genotype 1-6 chronic... Read more ››

STOCKHOLM, June 20, 2019 /PRNewswire/ -- Karo Pharma AB (publ) (the "Company" or "Karo Pharma") has today acquired all the shares of Trimb Holding AB ("Trimb") from Avista Capital Partners ("Avista") and other shareholders for MSEK 3,400 (the "Transaction").... Read more ››

STOCKHOLM, June 20, 2019 /PRNewswire/ -- Cyxone (publ.), a Swedish biotech in autoimmune diseases, today announced that the company starts its first-in-human, phase I, clinical trial with drug candidate T20K for the treatment of multiple sclerosis (MS) immediately following the authorities'... Read more ››

LUND, Sweden, June 20, 2019 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX), a commercial stage biopharmaceutical company specializing in long-acting medicines for severe and chronic disorders, announced today the acceptance by the US Food and Drug Administration (FDA) of an Investigational New Drug... Read more ››